** Shares of Healius HLS.AX rose as much as 8.1% to
A$1.405, their highest level since Nov 17
** Analysts at Morgan Stanley see earnings per share risk
for Healius, however, "upon a successful capital raising,
leverage should no longer be an overhang on the shares"
** Brokerage upgrades stock rating to "Equal-weight" from
"Underweight"
** Morgan Stanley says long-term growth rate assumption of
2.5% remains unchanged; upbeat on co's stock trading near
current price target of A$1.30
** One of 10 analysts rate stock "Buy", 7 rate "Hold" and 2
rate "sell" or lower; their median PT is A$1.47 - LSEG data
** Stock down 54.3% YTD as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
((Shivangi.Lahiri@thomsonreuters.com;))